Annual EBIT
-$3.95B$41.00M-1.05%
Summary
- Current Value
- As of today, MRNA annual EBIT is -$3.95B, down -1.05% on
- Historical Performance
- MRNA annual EBIT is down -129.67% over the past 3 years, and down -622.53% over the past 5 years
- All-Time High Comparison
- MRNA annual EBIT is currently -129.67% below its historical high of $13.30B set on
- 3-Year Low Comparison
- MRNA annual EBIT is at its 3-year low
- Sector Comparison
- MRNA annual EBIT is higher than 0.08% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$3.95B | -1.1% | -129.7% | -622.5% | -10000.0% | |
| Quarterly EBIT | -$260.00M | -271.4% | -123.3% | -10.6% | -3158.2% | |
| TTM EBIT | -$3.46B | -28.2% | -126.5% | -459.8% | -10000.0% | |
| Price | $33.84 | -19.9% | -82.0% | -72.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $3.24B | -52.7% | -82.4% | +5274.6% | +10000.0% | |
| Annual EPS | -$9.27 | +24.9% | -132.8% | -496.8% | +99.5% | |
| Annual EBITDA | -$3.76B | -14.4% | -127.8% | -629.3% | -10000.0% | |
| Annual Net Income | -$3.56B | +24.5% | -129.2% | -592.8% | -10000.0% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.60B | N/A | -141.1% |
| 5Y | $13.30B | -129.7% | |
| All | $13.30B | -129.7% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.95B | at low | |
| 5Y | -$3.95B | at low | |
| All | -$3.95B | at low |
EBIT History
FAQ
What is the current annual EBIT of MRNA?
As of today, MRNA annual EBIT is -$3.95B
What is 1-year change in MRNA annual EBIT?
MRNA annual EBIT is down -1.05% year-over-year
What is 3-year change in MRNA annual EBIT?
MRNA annual EBIT is down -129.67% over the past 3 years
How far is MRNA annual EBIT from its all-time high?
MRNA annual EBIT is currently -129.67% below its historical high of $13.30B set on December 31, 2021
How does MRNA annual EBIT rank versus sector peers?
MRNA annual EBIT is higher than 0.08% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly EBIT
-$260.00M$647.00M+71.33%
Summary
- Current Value
- As of today, MRNA quarterly EBIT is -$260.00M, up +71.33% on
- Historical Performance
- MRNA quarterly EBIT is down -271.43% year-over-year, and down -123.30% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EBIT is currently -104.87% below its historical high of $5.34B set on
- 3-Year Low Comparison
- MRNA quarterly EBIT is +87.08% above its 3-year low of -$2.01B reached on
- Sector Comparison
- MRNA quarterly EBIT is higher than 0.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$260.00M | +71.3% | -271.4% | -123.3% | -10.6% | |
| Annual EBIT | -$3.95B | – | -1.1% | -129.7% | -622.5% | |
| TTM EBIT | -$3.46B | -5.8% | -28.2% | -126.5% | -459.8% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.02B | +615.5% | -45.4% | -69.3% | +543.4% | |
| Quarterly EPS | -$0.51 | +75.9% | -1673.0% | -120.3% | +13.4% | |
| Quarterly EBITDA | -$208.00M | +75.5% | -1055.6% | -116.9% | +8.2% | |
| Quarterly Net Income | -$200.00M | +75.8% | -1638.5% | -119.2% | +14.4% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$260.00M | at high | |
| 3Y | $1.52B | N/A | -117.1% |
| 5Y | $5.34B | -104.9% | |
| All | $5.34B | -104.9% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.25B | N/A | +79.1% |
| 3Y | -$2.01B | +87.1% | |
| 5Y | -$2.01B | +87.1% | |
| All | -$2.01B | +87.1% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of MRNA?
As of today, MRNA quarterly EBIT is -$260.00M
What is MRNA quarterly EBIT most recent change?
MRNA quarterly EBIT was up +71.33% on September 30, 2025
What is 1-year change in MRNA quarterly EBIT?
MRNA quarterly EBIT is down -271.43% year-over-year
How far is MRNA quarterly EBIT from its all-time high?
MRNA quarterly EBIT is currently -104.87% below its historical high of $5.34B set on December 31, 2021
How does MRNA quarterly EBIT rank versus sector peers?
MRNA quarterly EBIT is higher than 0.45% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM EBIT
-$3.46B$190.00M-5.81%
Summary
- Current Value
- As of today, MRNA TTM EBIT is -$3.46B, down -5.81% on
- Historical Performance
- MRNA TTM EBIT is down -28.21% year-over-year, and down -126.46% over the past 3 years
- All-Time High Comparison
- MRNA TTM EBIT is currently -121.41% below its historical high of $16.17B set on
- 3-Year Low Comparison
- MRNA TTM EBIT is +32.72% above its 3-year low of -$5.15B reached on
- Sector Comparison
- MRNA TTM EBIT is higher than 0.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$3.46B | -5.8% | -28.2% | -126.5% | -459.8% | |
| Annual EBIT | -$3.95B | – | -1.1% | -129.7% | -622.5% | |
| Quarterly EBIT | -$260.00M | +71.3% | -271.4% | -123.3% | -10.6% | |
| Price | $33.84 | +26.1% | -19.9% | -82.0% | -72.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $2.23B | -27.5% | -56.0% | -89.5% | +804.7% | |
| TTM EPS | -$8.06 | -7.3% | -38.4% | -129.2% | -397.1% | |
| TTM EBITDA | -$3.26B | -6.2% | -37.3% | -124.2% | -455.3% | |
| TTM Net Income | -$3.12B | -7.3% | -40.1% | -126.5% | -420.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$3.27B | -5.8% | |
| 3Y | $9.27B | N/A | -137.4% |
| 5Y | $16.17B | -121.4% | |
| All | $16.17B | -121.4% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.95B | N/A | +12.2% |
| 3Y | -$5.15B | +32.7% | |
| 5Y | -$5.15B | +32.7% | |
| All | -$5.15B | +32.7% |
TTM EBIT History
FAQ
What is the current TTM EBIT of MRNA?
As of today, MRNA TTM EBIT is -$3.46B
What is MRNA TTM EBIT most recent change?
MRNA TTM EBIT was down -5.81% on September 30, 2025
What is 1-year change in MRNA TTM EBIT?
MRNA TTM EBIT is down -28.21% year-over-year
How far is MRNA TTM EBIT from its all-time high?
MRNA TTM EBIT is currently -121.41% below its historical high of $16.17B set on March 31, 2022
How does MRNA TTM EBIT rank versus sector peers?
MRNA TTM EBIT is higher than 0.18% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna